Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behcet disease uveitis and concomitant bladder papillary carcinoma

被引：10
|
作者：
Orlando, Ida [1 ]
Vitale, Antonio [1 ]
Rigante, Donato [2 ]
Lopalco, Giuseppe [3 ]
Fabiani, Claudia [4 ]
Cantarini, Luca [1 ]
机构：
[1] Univ Siena, Dept Med Sci Surg & Neurosci, Res Ctr System Autoinflammatory Dis & Behcets Dis, Siena, Italy
[2] Univ Cattolica Sacro Cuore, Inst Pediat, A Gemelli Hosp, Rome, Italy
[3] Interdisciplinary Dept Med, Rheumatol Unit, Bari, Italy
[4] Humanitas Clin & Res Ctr, Dept Ophthalmol, Milan, Italy
来源：
INTERNAL MEDICINE JOURNAL | 2017年 / 47卷 / 09期
关键词：
GROWTH;
D O I：
10.1111/imj.13538
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1086 / 1088
页数：4
相关论文
共 50 条
  • [41] Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients
    Atas, N.
    Eroglu, G. A.
    Sodan, H. N.
    Ozturk, B. O.
    Babaoglu, H.
    Satis, H.
    Karadeniz, H.
    Guler, A. A.
    Salman, R. B.
    Goker, B.
    Ozturk, M. A.
    Haznedaroglu, S.
    Tufan, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : S30 - S36
  • [42] Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease
    Yilmaz, Sedat
    Cinar, Muhammet
    Simsek, Ismail
    Erdem, Hakan
    Pay, Salih
    MODERN RHEUMATOLOGY, 2014, 24 (06) : 1030 - 1031
  • [43] Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behcet's disease
    Keino, Hiroshi
    Watanabe, Takayo
    Nakayama, Makiko
    Komagata, Yoshinori
    Fukuoka, Kazuhito
    Okada, Annabelle A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (11) : 1525 - 1533
  • [44] Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behcet Disease: National Study of 103 White Patients
    Luis Martin-Varillas, Jose
    Atienza-Mateo, Belen
    Calvo-Rio, Vanesa
    Beltran, Emma
    Sanchez-Burson, Juan
    Adan, Alfredo
    Hernandez-Garfella, Marisa
    Valls-Pascual, Elia
    Sellas-Fernandez, Agusti
    Ortego, Norberto
    Maiz, Olga
    Torre, Ignacio
    Fernandez-Espartero, Cruz
    Jovani, Vega
    Peiteado, Diana
    Diaz Valle, David
    Aurrecoechea, Elena
    Caracuel, Miguel A.
    Garcia-Gonzalez, Alfredo J.
    Raya Alvarez, Enrique
    Vegas-Revenga, Nuria
    Demetrio-Pablo, Rosalia
    Castaneda, Santos
    Gonzalez-Gay, Miguel A.
    Luis Hernandez, Jose
    Blanco, Ricardo
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) : 741 - 750
  • [45] Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva
    Haviv, Ruby
    Zeitlin, Leonid
    Moshe, Veronica
    Ziv, Amit
    Rabinowicz, Noa
    De Benedetti, Fabrizio
    Prencipe, Giusi
    Matteo, Valentina
    De Cunto, Carmen Laura
    Hsiao, Edward C.
    Uziel, Yosef
    RHEUMATOLOGY, 2024, 63 (09) : 2597 - 2604
  • [46] Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behcet's Uveitis Not Responding to Conventional Therapy
    Yang, Peizeng
    Huang, Guo
    Du, Liping
    Ye, Zi
    Hu, Ke
    Wang, Chaokui
    Qi, Jian
    Liang, Liang
    Wu, Lili
    Cao, Qingfeng
    Kijlstra, Aize
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 7 - 14
  • [47] Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone
    Nanas, JN
    Papazoglou, P
    Tsagalou, EP
    Ntalianis, A
    Tsolakis, E
    Terrovitis, JV
    Kanakakis, J
    Nanas, SN
    Alexopoulos, GP
    Anastasiou-Nana, MI
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06): : 768 - 771
  • [48] Short-term and long-term efficacy of anti-TNF-α antibody infliximab on refractory Entero-BehcEt's disease
    Shigeru, Iwata
    Saito, Kazuyosi
    Tsujimura, Shizuyo
    Yamaoka, Kunihiro
    Nakano, Kazuhisa
    Nawata, Masao
    Tanaka, Yoshiya
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S856 - S857
  • [49] Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors
    Fleischmann, Roy
    Genovese, Mark C.
    Maslova, Karina
    Leher, Henry
    Praestgaard, Amy
    Burmester, Gerd R.
    RHEUMATOLOGY, 2021, 60 (11) : 4991 - 5001
  • [50] SHORT AND LONG-TERM FOLLOW-UP WITH ADALIMUMAD IN REFRACTORY UVEITIS ASSOCIATED TO BEHCET'S DISEASE. MULTICENTER STUDY OF 74 PATIENTS
    Dominguez-Casas, L.
    Calvo-Rio, V.
    Beltran, E.
    S-Burson, J.
    Mesquida, M.
    Adan, A.
    Hernandez, M.
    H-Grafella, M.
    V-Pascual, E.
    M-Costa, L.
    Sellas, A.
    Cordero-Coma, M.
    Diaz-Llopis, M.
    Gallego, R.
    Salom, D.
    G-Serrano, J.
    Ortego, N.
    Herreras, J.
    G-Aparicio, A.
    Maiz, O.
    Blanco, A.
    Torre, I.
    Diaz-Valle, D.
    Pato, E.
    Aurrecoechea, E.
    Caracuel, M.
    Gamero, F.
    Minguez, E.
    Carrasco, C.
    Olive, A.
    Vazquez, J.
    R-Moreno, O.
    Manero, J.
    Munoz, S.
    Gandia, M.
    Rubio-Romero, E.
    Toyos-SMiera, F.
    Lopez-Longo, F.
    Nolla, J.
    Revenga, M.
    Vegas-Revenga, N.
    Fernandez-Diaz, C.
    Demetrio-Pablo, R.
    Gonzalez-Gay, M.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 326 - 326
12345